The development of biotherapeutics continues to accelerate with their potential to revolutionize disease treatment in areas not adequately addressed by small molecule therapeutics. However, the complexity of these macromolecules and the range of potential modification… Read more >
During 2020, we collaborated with many of our customers to develop targeted liquid chromatography–mass spectrometry/mass spectrometry (LC-MS/MS) methods to detect SARS-CoV-2 (the virus that causes COVID-19) from biological samples. However, the combination of the biological… Read more >
As the interest in peptides as potential drug candidates increases, the need for basic information about the isolation and purification of these peptides also grows.
Hello, I’m Andy Aubin, Principal Consulting Chemist at Waters. Jo-Ann Jablonski, Principal Scientist at Waters, and I recently conducted a webinar that addressed some techniques to make peptide purifications more efficient. We discussed three techniques:… Read more >
As regulators focus in on the critical quality attributes of biotherapeutics, what can biopharmaceutical labs in late development or QC do to increase confidence in their bioseparations – other than to run more assays?
